Products & ReviewLife Sciences

KU0060648

NHEJ pathway inhibitor; Inhibits DNA-dependent protein kinase (DNA-PK)

STEMCELL Technologies Inc.

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our  Product Directory.

Ease of Use
After Sales Service
Value for Money
Write your own review

KU0060648 is an ATP-competitive and highly potent inhibitor of DNA-dependent protein kinase (DNA-PK), with IC₅₀ values of 19 nM in MCF7 human breast cancer cells and 170 nM in SW620 human colon cancer cells. KU0060648 also inhibits phosphoinositide 3-kinase (PI3K) with IC₅₀ values of 39 nM in MCF7 cells and > 10 µM in SW620 cells, which suggests a cell-dependent mechanism (Munck et al.).

GENOME EDITING

  • Reduces the frequency of non-homologous end joining (NHEJ) and increases the efficiency of homology-directed repair (HDR) in CRISPR-Cas9 genome editing (Robert et al.).

CANCER RESEARCH

  • Inhibits tumor growth and sensitizes human cancer cells to DNA double-strand-break (DSB)-inducing therapies (chemo- or radio-therapy) by inhibiting both DNA-PK and PI3K and preventing the execution of DSB repair (Chen et al.; Dietlein et al.; Munck et al.).

Product Overview

Links